Relationship Between Frailty and Medicine Use and Polypharmacy in People Over Sixty-five Years of Age

被引:5
作者
Arslan, Mehmet [1 ]
Arslan, Elif Keskin [2 ]
Koc, Esra Meltem [3 ]
Sozmen, Melih Kaan [4 ]
Kaplan, Yusuf Cem [3 ]
机构
[1] Izmir Buca 26 Nolu Aile Sagligi Merkezi, Aile Hekimligi, Izmir, Turkey
[2] Izmir Katip Celebi Univ, Tip Fak, Tibbi Farmakoloji Anabilim Dali, Izmir, Turkey
[3] Izmir Katip Celebi Univ, Tip Fak, Aile Hekimligi Anabilim Dali, Izmir, Turkey
[4] Izmir Katip Celebi Univ, Tip Fak, Halk Sagligi Anabilim Dali, Izmir, Turkey
来源
HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI | 2020年 / 58卷 / 01期
关键词
Frailty; polypharmacy; medicine; walking speed; INDICATOR; PERFORMANCE; PREVALENCE; MEDICATION; OUTCOMES; RISK;
D O I
10.4274/haseki.galenos.2019.5409
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: Frailty has become an important health issue in recent years. The aim of this study was to investigate the relationship between frailty and medicine use and polypharmacy in people over 65 years of age. Methods: Patients aged 65 years and over, who were admitted to family medicine outpatient clinics, were included in the study. The Tilburg frailty indicator, timed up and go test and gait speed test were used. Multivariate linear and logistic regression model were conducted. Results: Individuals, who used five or more medicines (polypharmacy) daily, constituted 49.1% of all participants. 55.6% of patients on polypharmacy were frail. Gender (beta=0.560, 95% Cl=-0.943-0.177) and the number of chronic diseases (beta=1.496, 95% Cl=1.376-1.616) were found to have an effect on the total number of medicines. According to the results of logistic regression analysis on polypharmacy; female gender (aOR=3.4, 95% Cl=1.412-8.639), living alone (single/divorced/widowed) (aOR=2.8, 95% Cl=1.133-7.201) and number of chronic diseases (aOR=6.8, 95% Cl=4.218-11.075) were significantly associated with increased risk of polypharmacy. Conclusion: A significant increase in frailty score and reduction in walking speeds were detected in patients aged 65 years and over on polypharmacy. It should be kept in mind that polypharmacy is significantly related with frailty in elderly patients.
引用
收藏
页码:33 / 41
页数:9
相关论文
共 28 条
[1]  
Abolhassani N., 2018, J PATIENT SAF, P1
[2]  
[Anonymous], 2023, Suicide Statistics
[3]  
[Anonymous], 2024, China country assessment report on ageing and health[EB/OL]
[4]   THE TURKISH ADAPTATION OF THE TILBURG FRAILTY INDICATOR: A VALIDITY AND RELIABILITY STUDY [J].
Arslan, Mehmet ;
Meltem Koc, Esra ;
Sozmen, Melih Kaan .
TURKISH JOURNAL OF GERIATRICS-TURK GERIATRI DERGISI, 2018, 21 (02) :173-183
[5]  
Bilir N, 2007, YASLILIKTA KALITELI
[6]   Determinants of frailty: the added value of assessing medication [J].
Coelho, Tiago ;
Paul, Constanca ;
Gobbens, Robbert J. J. ;
Fernandes, Lia .
FRONTIERS IN AGING NEUROSCIENCE, 2015, 7
[7]   The Association of Medication-Use and Frailty-Related Factors with Gait Performance in Older Patients [J].
de Groot, Maartje H. ;
van Campen, Jos P. C. M. ;
Kosse, Nienke M. ;
de Vries, Oscar J. ;
Beijnen, Jos H. ;
Lamoth, Claudine J. C. .
PLOS ONE, 2016, 11 (02)
[8]   Prevalence, awareness, treatment and control of hypertension in Hellas, Greece [J].
Efstratopoulos, AD ;
Voyaki, SM ;
Baltas, AA ;
Vratsistas, FA ;
Kirlas, DEP ;
Kontoyannis, JT ;
Sakellariou, JG ;
Triantaphyllou, GB ;
Alokrios, GA ;
Lianas, DN ;
Vasilakis, EA ;
Fotiadis, KN ;
Kastritsea, EE .
AMERICAN JOURNAL OF HYPERTENSION, 2006, 19 (01) :53-60
[9]  
Fritz S, 2010, J GERIATRIC PHYS THE
[10]  
Gelal A., 2015, TURKIYE KLIN J PHARM, V3, P57